Showing results (141-150 of 188) with videos related to
Sort By:
Pageof 19
Annals of Surgical Oncology|April 15, 2006
Tumor bed boost omission after negative re-excision in breast-conservation treatmentDouglas W Arthur, Laurie W Cuttino, Andrew C Neuschatz, et al.Journal of Surgical Oncology|April 14, 2017
Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trialHarry D Bear, Wen Wan, André Robidoux, et al.BMC Cancer|March 30, 2011
The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell linesStacey L Fossey, Misty D Bear, Jiayuh Lin, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 19, 2011
Human dosimetry and preliminary tumor distribution of 18F-fluoropaclitaxel in healthy volunteers and newly diagnosed breast cancer patients using PET/CTKaren A Kurdziel, Joseph D Kalen, Jerry I Hirsch, et al.Journal of Translational Medicine|April 2, 2011
Tumor escape and progression of HER-2/neu negative breast cancer under immune pressureMaciej Kmieciak, Kyle K Payne, Michael O Idowu, et al.Anti-Cancer Drugs|May 1, 1996
Bryostatin 1 activates splenic lymphocytes and induces sustained depletion of splenocyte protein kinase C activity in vivo after a single intravenous administrationH D Bear, A W McFadden, P J Kostuchenko, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2018
Consecutive Day HSP90 Inhibitor Administration Improves Efficacy in Murine Models of KIT-Driven Malignancies and Canine Mast Cell TumorsCheryl A London, Jaime Acquaviva, Donald L Smith, et al.Annals of Surgery|June 1, 1996
Long-term results of breast conservation therapy for breast cancerP T Neff, H D Bear, C V Pierce, et al.Journal of Leukocyte Biology|July 10, 2018
Gr1-/low CD11b-/low MHCII+ myeloid cells boost T cell anti-tumor efficacyKyle K Payne, Hussein F Aqbi, Savannah E Butler, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2012
Cutting edge: mast cells critically augment myeloid-derived suppressor cell activitySheinei J Saleem, Rebecca K Martin, Johanna K Morales, et al.Pageof 19